Form 10-Q MEDICINES CO /DE For: Sep 30

Go back to Form 10-Q MEDICINES CO /DE For: Sep 30

Medicines Co. (MDCO), Alnylam' (ALNY) ALN-PCSsc Data Affirm Potential bi-Annual Dose Regimen - Chardan Capital

November 11, 2015 12:35 PM EST

Chardan Capital affirms Medicines Company (Nasdaq: MDCO) with a Buy rating and $50 price target after the company and Alnylam (Nasdaq: ALNY)... More